Q-omics provides the consensus-scored MIR21 profile across patient tissues and cancer cell-line models. Additionally, MIR21 RNA expression shows 1 significant drug associations, with the highest sampling consensus in PEMB_ALL.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MIR21 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with MIR21 in patient tissues and cancer cell lines. In patient samples, MIR21 shows the broadest associations at the RNA and protein expression levels, with PEMB_ALL recurring as the lineage with the largest associated feature set. In cancer cell lines, MIR21 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in LUNG_NSCLC_LUAD, while CRISPR and shRNA rows add functional-dependency signals in SKIN.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Drug	1	PEMB_ALL (1)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼shRNA
RNA	1,573	LUNG_NSCLC_LUAD (322)	view →
shRNA	1,179	SKIN (221)	view →